94 related articles for article (PubMed ID: 2113864)
1. Leukemia inhibitory factor suppresses proliferation, alkaline phosphatase activity, and type I collagen messenger ribonucleic acid level and enhances osteopontin mRNA level in murine osteoblast-like (MC3T3E1) cells.
Noda M; Vogel RL; Hasson DM; Rodan GA
Endocrinology; 1990 Jul; 127(1):185-90. PubMed ID: 2113864
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor inhibits osteogenic differentiation in rat calvaria cell cultures.
Malaval L; Gupta AK; Aubin JE
Endocrinology; 1995 Apr; 136(4):1411-8. PubMed ID: 7895651
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor binds with high affinity to preosteoblastic RCT-1 cells and potentiates the retinoic acid induction of alkaline phosphatase.
Rodan SB; Wesolowski G; Hilton DJ; Nicola NA; Rodan GA
Endocrinology; 1990 Oct; 127(4):1602-8. PubMed ID: 2119291
[TBL] [Abstract][Full Text] [Related]
4. Osteoblasts display receptors for and responses to leukemia-inhibitory factor.
Allan EH; Hilton DJ; Brown MA; Evely RS; Yumita S; Metcalf D; Gough NM; Ng KW; Nicola NA; Martin TJ
J Cell Physiol; 1990 Oct; 145(1):110-9. PubMed ID: 2170427
[TBL] [Abstract][Full Text] [Related]
5. Influence of DNA replication inhibition on expression of cell growth and tissue-specific genes in osteoblasts and osteosarcoma cells.
Kockx M; McCabe L; Stein JL; Lian JB; Stein GS
J Cell Biochem; 1994 Jan; 54(1):47-55. PubMed ID: 8126086
[TBL] [Abstract][Full Text] [Related]
6. Effect of platelet-derived growth factor on DNA synthesis and gene expression in bone marrow stromal cells derived from adult and old rats.
Tanaka H; Liang CT
J Cell Physiol; 1995 Aug; 164(2):367-75. PubMed ID: 7622582
[TBL] [Abstract][Full Text] [Related]
7. The role of type I collagen in the regulation of the osteoblast phenotype.
Shi S; Kirk M; Kahn AJ
J Bone Miner Res; 1996 Aug; 11(8):1139-45. PubMed ID: 8854250
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Chesnokova V; Melmed S
Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures.
Leboy PS; Beresford JN; Devlin C; Owen ME
J Cell Physiol; 1991 Mar; 146(3):370-8. PubMed ID: 2022691
[TBL] [Abstract][Full Text] [Related]
11. Modulation of PDGF mediated osteoblast chemotaxis by leukemia inhibitory factor (LIF).
Chandrasekhar S; Harvey AK
J Cell Physiol; 1996 Dec; 169(3):481-90. PubMed ID: 8952697
[TBL] [Abstract][Full Text] [Related]
12. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.
Harris SE; Bonewald LF; Harris MA; Sabatini M; Dallas S; Feng JQ; Ghosh-Choudhury N; Wozney J; Mundy GR
J Bone Miner Res; 1994 Jun; 9(6):855-63. PubMed ID: 8079661
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
[TBL] [Abstract][Full Text] [Related]
14. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells.
Marusić A; Kalinowski JF; Jastrzebski S; Lorenzo JA
J Bone Miner Res; 1993 May; 8(5):617-24. PubMed ID: 8511989
[TBL] [Abstract][Full Text] [Related]
15. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix.
Owen TA; Aronow M; Shalhoub V; Barone LM; Wilming L; Tassinari MS; Kennedy MB; Pockwinse S; Lian JB; Stein GS
J Cell Physiol; 1990 Jun; 143(3):420-30. PubMed ID: 1694181
[TBL] [Abstract][Full Text] [Related]
16. Regulation of osteoblast proliferation by leukemia inhibitory factor.
Lowe C; Cornish J; Callon K; Martin TJ; Reid IR
J Bone Miner Res; 1991 Dec; 6(12):1277-83. PubMed ID: 1792939
[TBL] [Abstract][Full Text] [Related]
17. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium.
Arici A; Engin O; Attar E; Olive DL
J Clin Endocrinol Metab; 1995 Jun; 80(6):1908-15. PubMed ID: 7775640
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human leukemia inhibitory factor is mitogenic for human bone-derived osteoblast-like cells.
Evans DB; Gerber B; Feyen JH
Biochem Biophys Res Commun; 1994 Feb; 199(1):220-6. PubMed ID: 8123016
[TBL] [Abstract][Full Text] [Related]
19. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.
Lecanda F; Avioli LV; Cheng SL
J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193
[TBL] [Abstract][Full Text] [Related]
20. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization.
Lynch MP; Stein JL; Stein GS; Lian JB
Exp Cell Res; 1995 Jan; 216(1):35-45. PubMed ID: 7813631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]